SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Preventive Visit — Calamity Jane

PatientMartha Canary
Date of birth1981-05-01
IdentifiersMRN HR-NI008-SYN; SSN (made up) 000-08-9532
Document date2026-04-27
AuthorRuth Ann Kessler, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit. [S]

History of Present Illness

Ms. Canary is a 44-year-old woman with severe alcohol use disorder in early remission on monthly extended-release naltrexone, and alcohol-associated steatotic liver disease, who comes for her yearly preventive visit four weeks after her four-week review; her second naltrexone injection is due today. She has had no alcohol since intake, eight weeks ago. She has had the urge to drink on a few evenings and called the peer recovery specialist twice. Her tooth socket has healed. She is eating two meals a day with SNAP benefits and has gained weight. She is still staying at her friend's house and is on the waiting list for a room through the housing program. She cannot remember a Pap test or a mammogram, or any vaccines as an adult. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 44
AlcoholNone for eight weeks; cravings on a few evenings
NaltrexoneSecond monthly injection due today
MoodPHQ-9 7; item 9 scored 0
MedicinesExtended-release naltrexone 380 mg every four weeks; thiamine 100 mg and folic acid 1 mg daily

Health risk assessment. Read aloud and completed with the patient by the clinic's community health worker, at her request, and reviewed with her by Dr. Kessler. [S]

DomainFinding
Self-rated healthFair, and better than two months ago
PsychosocialFriends in town; weekly contact with the peer recovery specialist; a women's mutual-help meeting on Thursdays
AlcoholNone for eight weeks; AUDIT 31 at intake
TobaccoChews tobacco daily; does not smoke
Physical activityPhysical work most days and walking everywhere
NutritionTwo meals a day on most days with SNAP benefits and the food bank
SleepSix hours, better than in the first weeks
Safety at homeFeels safe where she is staying; no one hurts or threatens her; her rifle is locked at her friend's house
Road safetyDoes not drive; gets rides or walks
Activities of daily livingIndependent
Hearing and visionNo difficulty
Oral healthOne molar removed last month; a dental cleaning booked at the community health center

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever, night sweats or weight loss; weight rising
EyesNegativeNo vision change
Ears, nose, mouth, and throatNegativeExtraction site healed
CardiovascularNegativeNo chest pain or palpitations
RespiratoryNegativeNo cough lasting more than two weeks, no blood in sputum
GastrointestinalNegativeNo abdominal pain, vomiting, black stools or yellowing of the eyes
GenitourinaryNegativePeriods irregular; no abnormal bleeding or discharge
MusculoskeletalNegativeAches after heavy work only
IntegumentaryNegativeNo rash; injection site from the last dose healed
NeurologicalNegativeNo tremor, numbness or unsteadiness
PsychiatricPositiveSome low days and evening cravings; PHQ-9 7; no thoughts of suicide or self-harm

11 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Gabapentin 300 mg oral capsule on a written five-day schedule for alcohol withdrawal: 300 mg in the morning, 300 mg in the afternoon and 600 mg at bedtime for three days, then 300 mg twice daily on day four, 300 mg at bedtime on day five, then stop; dispensed for the five days onlyPer the written five-day scheduleOral route2026-03-02 to 2026-03-06completedS
Thiamine 100 mg by intramuscular injection once daily for three days, given in the clinic100 mg intramuscularly once daily for three daysIntramuscular route2026-03-02 to 2026-03-04completedS
Thiamine 100 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-05activeS
Folic acid 1 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-02activeS
Potassium chloride extended-release 20 mEq oral tablet, one tablet daily with food for five daysOne tablet daily with food for five daysOral route2026-03-02 to 2026-03-06completedS
Magnesium oxide 400 mg oral tablet, one tablet twice daily for two weeksOne tablet twice daily for two weeksOral route2026-03-02 to 2026-03-16completedS
Naltrexone 50 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-09 to 2026-03-30completedS
Extended-release naltrexone 380 mg by deep intramuscular injection into the buttock every four weeks, given by the clinic nurse380 mg intramuscularly every four weeksIntramuscular route2026-03-30activeS
Amoxicillin 500 mg oral capsule, one capsule three times daily for five daysOne capsule three times daily for five daysOral route2026-03-23 to 2026-03-28completedS
Ibuprofen 400 mg oral tablet, one tablet with food every 8 hours as needed for tooth pain, for up to five daysOne tablet with food every 8 hours as needed, up to five daysOral route2026-03-23 to 2026-03-28completedS
Acetaminophen 500 mg oral tablet, one tablet every 6 hours as needed with the ibuprofen, no more than 2,000 mg a day, for up to five daysOne tablet every 6 hours as needed, no more than 2,000 mg a dayOral route2026-03-23 to 2026-03-28completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-04-27Body height165cmS
2026-04-27Body weight51.4kgS
2026-04-27Body mass index (BMI) [Ratio]18.9kg/m2S
2026-04-27Systolic blood pressure120mm[Hg]S
2026-04-27Diastolic blood pressure76mm[Hg]S
2026-04-27Heart rate76/minS
2026-04-27Respiratory rate16/minS
2026-04-27Body temperature36.6CelS
2026-04-27Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S
2026-04-27Cholesterol [Mass/volume] in Serum or Plasma168mg/dL<=199 mg/dLNormalS
2026-04-27Cholesterol in HDL [Mass/volume] in Serum or Plasma72mg/dL>=50 mg/dLNormalS
2026-04-27Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation80mg/dL<=99 mg/dLNormalS
2026-04-27Triglyceride [Mass/volume] in Serum or Plasma82mg/dL<=149 mg/dLNormalS

Physical Exam

Vital signs recorded on 2026-04-27; see the Vital Signs section. [S]

SystemFinding
ConstitutionalThin, well; weight 51.4 kg, BMI 18.9; blood pressure 120/76; pulse 76
EyesNo scleral icterus
MouthExtraction socket healed; several other decayed teeth
NeckNo thyroid enlargement or nodes
BreastsExamined with her consent and a chaperone present; no masses
CardiovascularRegular rhythm; no murmur
RespiratoryClear to auscultation
AbdomenSoft and non-tender; liver edge not palpable; no ascites
SkinNo spider angiomas or palmar erythema
NeurologicalNo tremor; gait steady

Problems

ProblemClinical statusVerificationCodeProvenance
Alcohol use disorder, severe (nine of eleven DSM-5-TR criteria), daily drinking of about a pint of whiskey with heavier binges for many years; synthetic modern episode linked to her documented lifelong heavy drinkingactiveconfirmed F10.20S — Synthetic modern coding; DSM-5-TR severe alcohol use disorder maps to F10.20 when withdrawal is coded separately. Person-first language; not a claim about her real diagnosis.
Alcohol withdrawal, mild, at low risk of complications (PAWSS 3, CIWA-Ar 9 at intake; no past seizures or delirium tremens), managed as an outpatient with daily nurse checksresolvedconfirmed F10.230S — Synthetic withdrawal episode; resolved by the one-week visit.
Raised liver enzymes (AST 96, ALT 44, GGT 240 U/L) with a FIB-4 index of 3.93, above the cut point for possible advanced fibrosis; liver stiffness measurement plannedresolvedconfirmed R74.01S — Synthetic presenting finding; superseded when elastography and the clinical picture supported alcohol-associated steatotic liver disease.
Alcohol-associated steatotic liver disease, without cirrhosis: liver stiffness 9.6 kPa after four weeks without alcohol, falling enzymes, normal bilirubin, albumin, INR and plateletsactiveconfirmed K70.0S — Synthetic modern diagnosis made at the four-week visit.
Depressive symptoms during heavy drinking (PHQ-9 14, item 9 scored 0); whether they are alcohol-induced or an independent depression to be judged after two to four weeks without alcoholactiveprovisional F32.AS — Synthetic provisional finding; resolved as the PHQ-9 fell to 5 after ten weeks without alcohol, consistent with alcohol-induced depressive symptoms. Not a claim about her real mood.
Daily chewing tobacco for many years; not ready to stop at intakeactiveconfirmed F17.220S — Synthetic modern coding anchored to the documented chewing tobacco.
Underweight (BMI 18.4) with poor food intake, low folate, magnesium and phosphate, and slightly low albuminactiveconfirmed R63.6S — Synthetic finding anchored to a contemporary impression of poor nutrition (R).
Housing instability: staying in a spare room at a friend's house, with nowhere to go if that ends; has stayed in shelters in past wintersactiveconfirmed Z59.811S — Synthetic social need anchored to her documented poverty and moves from town to town.
Food insecurity: often goes without meals at the end of the monthactiveconfirmed Z59.41S — Synthetic social need anchored to her documented poverty.
Periapical abscess of a lower left molar with facial swelling and low-grade fever, on naltrexone; treated without opioids, tooth removed at the dental clinic the next day; resolvedresolvedconfirmed K04.7S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today120/76 mmHg
Cervical cancer screeningCompleted todayNo screening she can recall; HPV test on a self-collected sample today
Breast cancer screeningOrderedMammography every two years from 40; ordered at the mobile unit, with transport arranged
Colorectal cancer screeningNot indicatedBegins at 45, next year
Lipid screening and cardiovascular riskCompleted todayTotal cholesterol 168, HDL 72, LDL 80, triglycerides 82 mg/dL; 10-year risk low; statin not indicated
Diabetes screeningNot indicatedRecommended at 35 to 70 for adults with overweight or obesity; BMI 18.9
HIV screeningUp to dateNegative at intake
Hepatitis C screeningUp to dateAntibody negative at intake
Hepatitis B screeningUp to dateTriple panel at intake: not infected and not immune
Latent tuberculosis screeningOrderedInterferon-gamma release assay today; she has stayed in shelters
Intimate partner violence screeningCompleted todayNegative now; past violence by a former partner, discussed only as far as she wished
Depression screeningCompleted todayPHQ-9 7, from 14 at intake; item 9 scored 0
Unhealthy alcohol useUp to dateIn treatment; no alcohol for eight weeks
Tobacco cessationDeclinedChews tobacco daily; advice given and nicotine lozenges offered; she will be asked again at each visit
Tetanus, diphtheria, and pertussisCompleted todayTdap today
Hepatitis B vaccineCompleted todayFirst of two HepB-CpG doses; second in one month or more
Hepatitis A vaccineCompleted todayFirst of two doses for chronic liver disease; second in six months
Pneumococcal vaccineCompleted todayPCV20 today; indicated by alcohol use disorder and chronic liver disease
Influenza vaccineNot indicatedSeason over; to be given in the autumn
HPV vaccineDeclinedShared decision-making for adults 27 to 45; she chose not to have it

Immunizations given today: Tdap vaccine; no tetanus booster she can recall; Hepatitis B vaccine (HepB-CpG), first of two doses; not immune at intake; Hepatitis A vaccine, adult, first of two doses; Pneumococcal conjugate vaccine (PCV20) [S]

Guideline basis: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Ten-week review in two weeks. HPV, tuberculosis test and mammogram results at the next visits. Second hepatitis B dose in one month or more; second hepatitis A dose in six months. Naltrexone injection at a nurse visit in four weeks. Next preventive visit in one year. Next scheduled visit 2026-05-11: ten-week review: recovery, mood, housing and results. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 16 minutes, with her consent. She named a health care agent, the friend she is staying with, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. She said that what matters most to her is her independence and her friends, and that she wants to be told the truth about her health in plain words. She chose not to record specific treatment preferences today. The plan will be revisited yearly or after any serious illness. [S]